Chattem Trolamine Salicylate Arthritis, Muscle Pain Studies Urged By FDA
This article was originally published in The Tan Sheet
Executive Summary
Chattem should consider allowing study subjects to apply 10% trolamine salicylate cream to any painful joints or muscles, although efficacy studies could focus only on a single joint or muscle, FDA Division of OTC Drug Products Director Charles Ganley, MD, said at a May 1 feedback meeting.